Source: http://www.google.com/patents/US5993374?dq=mirroring+data+in+a+remote+data+storage+system
Timestamp: 2014-07-10 04:00:05
Document Index: 759705237

Matched Legal Cases: ['art 2', 'art 2', 'art 2', 'art 2', 'art 1', 'art 1']

Patent US5993374 - Microcapsules for site-specific delivery - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign in<nobr>Advanced Patent Search</nobr>PatentsDisclosed is a site specific microcapsule delivery system and microcapsules for delivering one or more active agents to a preselected site. The system includes a catheter and microcapsules. A preferred embodiment of the catheter includes an inner inflatable balloon having an outer perforated delivery...http://www.google.com/patents/US5993374?utm_source=gb-gplus-sharePatent US5993374 - Microcapsules for site-specific deliveryAdvanced Patent SearchPublication numberUS5993374 APublication typeGrantApplication numberUS 08/877,593Publication dateNov 30, 1999Filing dateJun 17, 1997Priority dateJun 17, 1997Fee statusPaidPublication number08877593, 877593, US 5993374 A, US 5993374A, US-A-5993374, US5993374 A, US5993374AInventorsGeorge F. KickOriginal AssigneeRadiance Medical Systems, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (31), Non-Patent Citations (43), Referenced by (41), Classifications (10), Legal Events (6) External Links: USPTO, USPTO Assignment, EspacenetMicrocapsules for site-specific deliveryUS 5993374 AAbstract Disclosed is a site specific microcapsule delivery system and microcapsules for delivering one or more active agents to a preselected site. The system includes a catheter and microcapsules. A preferred embodiment of the catheter includes an inner inflatable balloon having an outer perforated delivery balloon concentrically disposed thereon. The microcapsule preferably comprises a water dissolvable core, and at least one outer protective shell. In a preferred embodiment, the core comprises phosphorous 31 and the outer shell comprises PGLA or other water soluble material. Neutron beam activation of the core produces phosphorous 32, for emitting therapeutic radiation to the treatment site. The outer protective shell dissipates over time, and, following a predetermined delivery period, the outer shell is removed and the central core dissipates to leave only biologically compatible break down products.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS2911338 *Mar 9, 1954Nov 3, 1959Abbott LabCapsules and method of producingUS3159545 *Oct 4, 1960Dec 1, 1964Abbott LabRadioactive capsulesUS3663685 *Apr 1, 1968May 16, 1972Minnesota Mining & MfgBiodegradable radioactive particlesUS3758678 *Sep 26, 1968Sep 11, 1973Minnesota Mining & MfgBiodegradable radioactive polysaccharide particlesUS4115536 *Sep 10, 1975Sep 19, 1978Pharmacia Fine Chemicals AbAgent for intravascular administrationUS4124705 *Jun 2, 1975Nov 7, 1978Pharmacia AktiebolagAgent for intravascular administrationUS4126669 *Feb 9, 1977Nov 21, 1978Pharmacia AktiebolagDiagnostic agentUS4225790 *Nov 27, 1978Sep 30, 1980Technical Operations, IncorporatedStorage reel assemblyUS4247406 *Apr 23, 1979Jan 27, 1981Widder Kenneth JIntravascularly-administrable, magnetically-localizable biodegradable carrierUS4349529 *Apr 14, 1980Sep 14, 1982E. R. Squibb & Sons, Inc.Diagnostic and therapeutic capsules and method of producingUS4409966 *May 29, 1981Oct 18, 1983Lambrecht Richard MMethod and apparatus for injecting a substance into the bloodstream of a subjectUS4674480 *Jul 17, 1984Jun 23, 1987Lemelson Jerome HDrug compositions and methods of applying sameUS4706652 *Dec 30, 1985Nov 17, 1987Henry Ford HospitalTemporary radiation therapyUS4745907 *Sep 16, 1987May 24, 1988Nuclear Medicine, Inc.System and method for delivering insoluble materials into a living bodyUS4819618 *Mar 11, 1987Apr 11, 1989Liprie Sam FIridium/platinum implant, method of encapsulation, and method of implantationUS5011677 *Aug 18, 1988Apr 30, 1991The Curators Of The University Of MissouriFor radiation therapyUS5019369 *Dec 1, 1988May 28, 1991Vestar, Inc.Method of targeting tumors in humansUS5081110 *Dec 13, 1988Jan 14, 1992Sloan-Kettering Institute For Cancer ResearchMethod of killing sarcoma cells using fludarabine phosphate and ionizing radiationUS5213561 *Mar 19, 1992May 25, 1993Weinstein Joseph SMethod and devices for preventing restenosis after angioplastyUS5295962 *Dec 18, 1992Mar 22, 1994Cardiovascular Dynamics, Inc.Drug delivery and dilatation catheterUS5302168 *Sep 5, 1991Apr 12, 1994Hess Robert LMethod and apparatus for restenosis treatmentUS5302369 *Aug 29, 1991Apr 12, 1994The Curators Of The University Of MissouriMicrospheres for radiation therapyUS5342283 *Aug 13, 1990Aug 30, 1994Good Roger REndocurietherapyUS5411466 *Mar 28, 1994May 2, 1995Robert L. HessApparatus for restenosis treatmentUS5421826 *Jan 13, 1994Jun 6, 1995Cardiovascular Dynamics, Inc.Drug delivery and dilatation catheter having a reinforced perfusion lumenUS5424288 *Jan 26, 1994Jun 13, 1995Order; Stanley E.Prolonging time therapeutic agent remains in tumorUS5498227 *Sep 15, 1993Mar 12, 1996Mawad; Michel E.Retrievable, shielded radiotherapy implantUS5503613 *Jan 21, 1994Apr 2, 1996The Trustees Of Columbia University In The City Of New YorkApparatus and method to reduce restenosis after arterial interventionUS5609886 *Jul 26, 1995Mar 11, 1997Teva Pharmaceutical Industries Ltd.Drug deliveryGB1133219A * Title not availableWO1993004735A1 *Sep 4, 1992Mar 18, 1993Cedars Sinai Medical CenterMethod and apparatus for restenosis treatment* Cited by examinerNon-Patent CitationsReference1 *A New Approach for Local Intravascular Drug Delivery (Iontophoretic Balloon). Antonio Fernandez Ortiz, MD, PhD; Beat J. Meyer, MD; Alessandra Mailhac, MD, PhD; Erling Falk, MD; Lina Badimon, PhD; John T. Fallon, MD, PhD; Valentin Fuster, MD, PhD; James H. Chesebro, MD; Juan J. Badimon, PhD, American Heart Association, Circulation vol. 89, No. 4, Apr. 1994.2A New Approach for Local Intravascular Drug Delivery (Iontophoretic Balloon). Antonio Fernandez-Ortiz, MD, PhD; Beat J. Meyer, MD; Alessandra Mailhac, MD, PhD; Erling Falk, MD; Lina Badimon, PhD; John T. Fallon, MD, PhD; Valentin Fuster, MD, PhD; James H. Chesebro, MD; Juan J. Badimon, PhD, American Heart Association, Circulation vol. 89, No. 4, Apr. 1994.3A Survey of Microencapsulation Processes, "Microencapsulation: Methods and Industrial Applications", 1996 by Marcel Dekker, Inc.4 *A Survey of Microencapsulation Processes, Microencapsulation: Methods and Industrial Applications , 1996 by Marcel Dekker, Inc.5 *Abstracts from the 66th Scientific Sessions, Georgia World Congress Center, Atlanta, Georgia, Nov. 8 11, 1993, American Heart Association, Supplement to Circulation, vol. 88, No. 4, Part 2, Oct. 1993.6Abstracts from the 66th Scientific Sessions, Georgia World Congress Center, Atlanta, Georgia, Nov. 8-11, 1993, American Heart Association, Supplement to Circulation, vol. 88, No. 4, Part 2, Oct. 1993.7 *Abstracts From the 67th Scientific Sessions, Dallas Convention Center, Dallas, TX, Nov. 14 17, 1994, American Heart Association, Circulation, vol. 90, No. 4, Part 2, Oct. 1994.8Abstracts From the 67th Scientific Sessions, Dallas Convention Center, Dallas, TX, Nov. 14-17, 1994, American Heart Association, Circulation, vol. 90, No. 4, Part 2, Oct. 1994.9 *Centrifugal Extrusion Encapsulation , Encapsulation and Controlled Release of Food Ingredients , Chapter 9, American Chemical Society, Washington, DC 1995.10Centrifugal Extrusion Encapsulation, "Encapsulation and Controlled Release of Food Ingredients", Chapter 9, American Chemical Society, Washington, DC 1995.11Direct Intraarterial Wall Injection of Microparticles via a Catheter: A Potential Drug Delivery Strategy Following Angioplasty; Robert L. Wilensky, MD, Keith L. March, MD, PhD, and David R. Hathaway, MD, "Progress in Cardiology" American Heart Association, vol. 122, No. 4, Part 1.12 *Direct Intraarterial Wall Injection of Microparticles via a Catheter: A Potential Drug Delivery Strategy Following Angioplasty; Robert L. Wilensky, MD, Keith L. March, MD, PhD, and David R. Hathaway, MD, Progress in Cardiology American Heart Association, vol. 122, No. 4, Part 1.13 *Endovascular Low Dose Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in Swine (A Possible Role for Radiation Therapy in Restenosis Prevention), Ron Waksman, MD; Keith A. Robinson, PhD; Iam R. Crocker, MD; Michael B. Gravanis, MD; Gustavo D. Cipolla, DVM; Spencer B. King III, MD; American Heart Association , Circulation, vol. 91, No. 5, Mar. 1, 1995.14Endovascular Low-Dose Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in Swine (A Possible Role for Radiation Therapy in Restenosis Prevention), Ron Waksman, MD; Keith A. Robinson, PhD; Iam R. Crocker, MD; Michael B. Gravanis, MD; Gustavo D. Cipolla, DVM; Spencer B. King III, MD; "American Heart Association", Circulation, vol. 91, No. 5, Mar. 1, 1995.15 *Intracoronary Irradiation Markedly Reduces Restenosis After Balloon Angioplasty in a Porcine Model, Joseph G. Wiedermann, MD, Charles Marboe, MD, Howard Amols, PhD, Allan Schwartz, MD, FACC, Judah Weinberger, MD, PhD, FACC, American College of Cardiology, JACC, vol. 23, No. 6, May 1994: 1491 8.16Intracoronary Irradiation Markedly Reduces Restenosis After Balloon Angioplasty in a Porcine Model, Joseph G. Wiedermann, MD, Charles Marboe, MD, Howard Amols, PhD, Allan Schwartz, MD, FACC, Judah Weinberger, MD, PhD, FACC, American College of Cardiology, JACC, vol. 23, No. 6, May 1994: 1491-8.17 *Journal of the American College of Cardiology , Abstracts of Original Contributions , JACC, vol. 21, No. 2, Feb. 1993.18Journal of the American College of Cardiology, "Abstracts of Original Contributions", JACC, vol. 21, No. 2, Feb. 1993.19 *Local Delivery, of Biodegradable Microparticles Containing Colchicine or a Colchicine Analogue: Effects on Restenosis and Implications for Catheter Based Drug Delivery, Irmina Gradus Pizlo, MD, Robert L. Wilensky, MD FACC, Keith L. March, MD, PhD, FACC, Naomi Fineberg, PhD, Marybeth Michaels, MS, George E. Sandusky, DVM, PhD David R. Hathaway, MD, FACC, American College of Cardiology Nov. 15, 1995, vol. 26, No. 6.20Local Delivery, of Biodegradable Microparticles Containing Colchicine or a Colchicine Analogue: Effects on Restenosis and Implications for Catheter-Based Drug Delivery, Irmina Gradus-Pizlo, MD, Robert L. Wilensky, MD FACC, Keith L. March, MD, PhD, FACC, Naomi Fineberg, PhD, Marybeth Michaels, MS, George E. Sandusky, DVM, PhD David R. Hathaway, MD, FACC, "American College of Cardiology" Nov. 15, 1995, vol. 26, No. 6.21 *Local Drug Delivery Catheters: Functional Comparison of Porous and Microporous Designs, Charles R. Lambert, MD, PhD, James E. Leone, AB, BS, and Stephen M. Rowland, PhD, Coronary Artery Disease May 1993, vol. 4 No. 5.22Local Intramural Drug Delivery Using an Infusion Balloon Following Angioplasty in Normal and Atherosclerotic Vessels, "Catheterization and Cardiovascular Diagnosis", vol. 31, No. 3, Mar. 1994.23 *Local Intramural Drug Delivery Using an Infusion Balloon Following Angioplasty in Normal and Atherosclerotic Vessels, Catheterization and Cardiovascular Diagnosis , vol. 31, No. 3, Mar. 1994.24 *Low Dose, Particle Emission From Stent Wire Results in Complete, Localized Inhibition of Smooth Muscle Cell Proliferation, Tim A. Fischell, MD, Bassam K. Kharma, MD; David R. Fischell, PhD; Peter G. Loges, BS; Circulation, vol. 90, No. 6, Dec. 1994.25Low-Dose, β-Particle Emission From `Stent` Wire Results in Complete, Localized Inhibition of Smooth Muscle Cell Proliferation, Tim A. Fischell, MD, Bassam K. Kharma, MD; David R. Fischell, PhD; Peter G. Loges, BS; Circulation, vol. 90, No. 6, Dec. 1994.26 *Microencapsulation and Related Drug Processes , Solvent Evaporation Process , Patrick B. Deasey, Marcel Dekker, Inc., 1984.27Microencapsulation and Related Drug Processes, "Solvent Evaporation Process", Patrick B. Deasey, Marcel Dekker, Inc., 1984.28Microencapsulation of Multiple Drugs, "Life Sciences" Lyndon B. Johnson Space Center, Houston Texas, NASA Tech Briefs, Nov. 1996.29 *Microencapsulation of Multiple Drugs, Life Sciences Lyndon B. Johnson Space Center, Houston Texas, NASA Tech Briefs, Nov. 1996.30 *Microspheres , Robert L. Wilensky & Keith L. March, Semin Intervent Cardio, 1996; 1: 48 50.31Microspheres, Robert L. Wilensky & Keith L. March, Semin Intervent Cardio, 1996; 1: 48-50.32 *Prophylactic Endovascular Radiotherapy to Prevent Intimal Hyperplasia after Stent Implantation in Femoropopliteal Arteries, Dieter Liermann, Heinz D. Bottcher, Jurgen Kollath, Bernd Schopohl, Gerd Strassmann Ernst P. Strecker, Karl H. Breddin, CardioVascular and Interventional Radiology, (1994) 17:12 16.33Prophylactic Endovascular Radiotherapy to Prevent Intimal Hyperplasia after Stent Implantation in Femoropopliteal Arteries, Dieter Liermann, Heinz D. Bottcher, Jurgen Kollath, Bernd Schopohl, Gerd Strassmann Ernst-P. Strecker, Karl H. Breddin, CardioVascular and Interventional Radiology, (1994) 17:12-16.34 *Pure Particle Emitting Stents Inhibit Neointima Formation in Rabbits, Brief Rapid Communications, Circulation, vol. 93, No. 4, Feb. 15, 1996.35Pure β-Particle-Emitting Stents Inhibit Neointima Formation in Rabbits, Brief Rapid Communications, Circulation, vol. 93, No. 4, Feb. 15, 1996.36 *Regional and Arterial Localization of Radioactive Microparticles After Local Delivery by Unsupported or Supported Porous Balloon Catheters, Robert L. Wilensky, MD, Keith L. March, MD, PhD, Irmina Gradus Pizlo, MD, Donald Schauwecker, MD, PhD, MaryBeth Michaels, MS, Janine Robinson, MS, Kathy Carlson, and David R. Hathaway, MD, American Heart Journal (1995) vol. 129, No. 5, pp. 852 859.37Regional and Arterial Localization of Radioactive Microparticles After Local Delivery by Unsupported or Supported Porous Balloon Catheters, Robert L. Wilensky, MD, Keith L. March, MD, PhD, Irmina Gradus-Pizlo, MD, Donald Schauwecker, MD, PhD, MaryBeth Michaels, MS, Janine Robinson, MS, Kathy Carlson, and David R. Hathaway, MD, "American Heart Journal" (1995) vol. 129, No. 5, pp. 852-859.38The Art and Science of Microencapsulation, Southwest Research Institute, San Antonio, Texas, Reprinted from the Jun. 1995 issue of "Technology Today", Brochure.39 *The Art and Science of Microencapsulation, Southwest Research Institute, San Antonio, Texas, Reprinted from the Jun. 1995 issue of Technology Today , Brochure.40 *The Dose Distribution Produced by a 32 P coated stent, W.V. Prestwich and T.J. Kennett, F.W. Kus, Medical Physics, vol. 22, No. 3, Mar. 1995.41The Dose Distribution Produced by a 32 P-coated stent, W.V. Prestwich and T.J. Kennett, F.W. Kus, Medical Physics, vol. 22, No. 3, Mar. 1995.42The Making of Microcapsules, Southwest Research Institute, San Antonio, Texas, Reprint from Sep. 1989 Edition of "Technology Today", Brochure.43 *The Making of Microcapsules, Southwest Research Institute, San Antonio, Texas, Reprint from Sep. 1989 Edition of Technology Today , Brochure.* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS6375634Apr 6, 1999Apr 23, 2002Oncology Innovations, Inc.Apparatus and method to encapsulate, kill and remove malignancies, including selectively increasing absorption of x-rays and increasing free-radical damage to residual tumors targeted by ionizing and non-ionizing radiation therapyUS6428811Jul 14, 2000Aug 6, 2002Wm. Marsh Rice UniversityTemperature-sensitive polymer/nanoshell composites for photothermally modulated drug deliveryUS6506437 *Oct 17, 2000Jan 14, 2003Advanced Cardiovascular Systems, Inc.Methods of coating an implantable device having depots formed in a surface thereofUS6517533 *May 4, 1999Feb 11, 2003M. J. SwaminathanBalloon catheter for controlling tissue remodeling and/or tissue proliferationUS6530944Feb 8, 2001Mar 11, 2003Rice UniversityLocalized delivery of heat and biological imaging materialsUS6537195May 7, 2001Mar 25, 2003Xoft, Microtube, Inc.Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasiaUS6544582Jan 5, 2001Apr 8, 2003Advanced Cardiovascular Systems, Inc.Method and apparatus for coating an implantable deviceUS6575888 *Jan 24, 2001Jun 10, 2003Biosurface Engineering Technologies, Inc.Bioabsorbable brachytherapy deviceUS6645517Jun 5, 2002Nov 11, 2003William Rice Marsh Rice UniversityWhich absorbs electromagnetic radiation, and uses the energy to trigger drug delivery; for multiples injections; diabetesUS6884427Feb 8, 2000Apr 26, 2005Aderans Research Institute, Inc.Filamentary means for introducing agents into tissue of a living hostUS6991681Feb 19, 2003Jan 31, 2006Advanced Cardiovascular Systems, Inc.Method and apparatus for coating an implantable deviceUS7008642Feb 12, 2001Mar 7, 2006Advanced Cardiovascular Systems, Inc.Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the sameUS7018371May 7, 2001Mar 28, 2006Xoft, Inc.Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasiaUS7041046May 7, 2001May 9, 2006Xoft, Inc.Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasiaUS7118729Jul 11, 2000Oct 10, 2006Civatech CorporationRadioactive source materials formable into various shapesUS7186459 *Jul 9, 2002Mar 6, 2007Canon Kabushiki KaishaHolding capability for hydrophilic and lipophilic drugs, water-soluble and hydrophobic substaces; controlling sustained releaseUS7198641Aug 7, 2001Apr 3, 2007Aderans Research Institute, Inc.Scaffolds for tissue engineered hairUS7354391Nov 7, 2003Apr 8, 2008Cytyc CorporationImplantable radiotherapy/brachytherapy radiation detecting apparatus and methodsUS7494457Nov 7, 2003Feb 24, 2009Cytyc CorporationBrachytherapy apparatus and method for treating a target tissue through an external surface of the tissueUS7524274Nov 7, 2003Apr 28, 2009Cytyc CorporationTissue positioning systems and methods for use with radiation therapyUS7524275Nov 14, 2003Apr 28, 2009Cytyc CorporationDrug eluting brachytherapy methods and apparatusUS7597885Mar 26, 2004Oct 6, 2009Aderans Research Institute, Inc.Scaffolds; keratinocytes; biocompatabilityUS7686756Aug 28, 2007Mar 30, 2010Ciratech OncologyBrachytherapy devices and related methods and computer program productsUS7780635Feb 8, 2007Aug 24, 2010Aderans Research Institute, Inc.Apparatus and methods for delivering fluid and material to a subjectUS7985537Jun 12, 2007Jul 26, 2011Aderans Research Institute, Inc.Methods for determining the hair follicle inductive properties of a compositionUS8012455Apr 26, 2006Sep 6, 2011Civatech CorporationRadioactive source materials formable into various shapesUS8057824Aug 26, 2008Nov 15, 2011Abbott Cardiovascular Systems Inc.Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the sameUS8206335Jul 14, 2010Jun 26, 2012Aderans Research Institute, Inc.Apparatus and methods for delivering fluid and material to a subjectUS8585648 *Jul 19, 2011Nov 19, 2013Minipumps, LlcCatheter drug pumpUS8632820Sep 24, 2011Jan 21, 2014Abbott Cardiovascular Systems Inc.Compositions for achieving a therapeutic effect in an anatomical structureUS8696539 *Jan 7, 2006Apr 15, 2014Acrostak Corp. BviPositioning device and a procedure for treating the walls of a resection cavityUS20080045773 *Jan 7, 2006Feb 21, 2008Youri PopowskiPositioning Device and a Procedure for Treating the Walls of a Resection CavityUS20100098754 *Oct 21, 2008Apr 22, 2010Southwest Research InstituteProcessing of heat-sensitive active agentsUS20100173278 *Jun 12, 2008Jul 8, 2010Cooperative Bretonne D'insemination Artificielle PorcineMicrocapsules containing mammals' spermatozoids, insemination dose containing same and method for obtaining sameUS20120016299 *Jul 19, 2011Jan 19, 2012Minipumps, LlcCatheter drug pumpUS20120310158 *Aug 16, 2012Dec 6, 2012Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc.Balloon catheter having metal balloon and method of making sameEP1426063A2 *Jul 11, 2000Jun 9, 2004Civatech CorporationFormable integral source material for medical and industrial devicesWO2000045736A1 *Feb 8, 2000Aug 10, 2000Thomas H BarrowsFilamentary means for introducing agents into cellsWO2000059422A1 *Jan 20, 2000Oct 12, 2000Oncology Innovations IncApparatus and method to encapsulate, kill and remove malignancies, including selectively increasing absorption of x-rays and increasing free-radical damage to residual tumors targeted by ionizing and non-ionizing radiation therapyWO2001005586A1 *Jul 14, 2000Jan 25, 2001Univ Wm Marsh RiceTemperature-sensitive polymer/nanoshell composites for photothermally modulated drug deliveryWO2012025930A2 *Aug 25, 2011Mar 1, 2012Ocure Ltd.Medical instruments of treating and/or diagnosing of anorectal disorders, and devices and methods for insertion of such* Cited by examinerClassifications U.S. Classification600/8International ClassificationA61M36/04, A61N5/10, A61M31/00, A61K51/12Cooperative ClassificationA61K51/1251, A61M31/002, A61N5/1002European ClassificationA61K51/12M4, A61M31/00DLegal EventsDateCodeEventDescriptionDec 7, 2010FPAYFee paymentYear of fee payment: 12May 24, 2007FPAYFee paymentYear of fee payment: 8Nov 26, 2003SULPSurcharge for late paymentNov 26, 2003FPAYFee paymentYear of fee payment: 4Jun 18, 2003REMIMaintenance fee reminder mailedJan 20, 1998ASAssignmentOwner name: CARDIOVASCULAR DYNAMICS, INC., CALIFORNIAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KICK, GEORGE F.;REEL/FRAME:008946/0119Effective date: 19980108RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services©2012 Google